The past decade has seen a number of new molecular diagnostic and therapeutic imaging agents enter clinical practice, especially in oncology, cardiology, and the neurosciences. The UC San Francisco Department of Radiology and Biomedical Imaging has served, decade after decade, as a hub for basic and translational research in this area driving the innovation of new agents, undertaking preclinical studies to demonstrate their potential and safety, and advancing their use for state-of-the-art clinical care.
To meet the challenges introduced at the cutting edge of a rapidly growing clinical field, the department is inaugurating a new clinical section, Molecular Imaging and Therapeutics (MI&T). This section will oversee the clinical practice of not only traditional nuclear medicine, but also the adoption of multimodality PET/CT and PET/MR and implementation of new diagnostic and…
